Skip to main content
Publications
Metcalfe KA, Price MA, Mansfield C , Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Evans DG, Narod SA, Liede A. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis . Br J Cancer. 2020 Jul 21;123:268-74. doi: 10.1038/s41416-020-0861-3
Elmasry MA, Sampani K, Abdelal OM, Fleming A , Souka A, Elbaha S, Silva PS, Sun JK, Aiello LP. Disparity of microaneurysm count between ultrawide field color imaging (UWF-CI) and ultrawide field fluorescein angiography (UWF-FA) in eyes with diabetic retinopathy . Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun; 61(7):5306.
Silva PS, Cavallerano J, Elmasry MA, Fleming A , van Hemert J, Lewis D, Bhaskar V, Tolson A, Tolls D, Sun JK, Aiello LP. Impact of visible retinal area on diabetic retinopathy severity and detection of predominantly peripheral lesions when using ultrawide field imaging . Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun 1; 61(7):3201.
Shokrollahi S, Elmasry MA, Sampani K, Pisig AU, Abdelal O, Robertson G, Fleming A , Pitoc CM, Sun JK, Silva PS, Aiello LP. Association of ultrawide field (UWF) retinal vessel caliber with diabetic retinopathy (DR) severity, predominantly peripheral lesions (PPL) and retinal nonperfusion (NP) . Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4771.
Silva PS, Stanton RC, Elmasry MA, Fleming A , Pellegrini E, van Hemert J, Tolls D, Tolson AM, Lewis D, Stainback J, Cavallerano JD, Sun JK, Aiello LP. Association of systemic comorbities with predominantly peripheral diabetic retinopathy lesions (PPL) identified on ultrawide field (UWF) retinal imaging . Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4772.
Pisig AU, Sampani K, Elmasry MA, Aldairy Y, Robertson G, Fleming A , Pitoc C, Rhee J, Sun JK, Silva PS, Aiello LP. Regional vessel caliber, retinal oximetry and predominantly peripheral diabetic retinal lesions as surrogate markers of nonperfusion on ultrawide field angiography in diabetic eyes . Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):3448.
Sears CM, Hirano T, Nittala MG, Mehta NS, Sinha S, Jayadev C, Singh G, Verhoek M, Fleming A , van Hmert J, Tsui I, Prasad P, Sadda SR. Ethnic variation in diabetic retinopathy lesion distribution . Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):4681.
Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martinez-Cardus A, Marin-Aguilera M, Horndler C, Martinez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martin-Richard M, Alonso V, Escudero P, Fernandez-Martos C, Feliu J, Mendez JC, Mendez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, Garcia-Albeniz X , Camps J, Maurel J. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer . Br J Cancer. 2017 Dec 5;117(12):1777-86. doi: 10.1038/bjc.2017.279.
Garcia-Albeniz X , Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA, Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fuchs CS, Hoffmeister M, Butterbach K, Du M, James Gauderman W, Gunter MJ, Lemire M, Ogino S, Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS, Jenkins MA, Thibodeau SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper JL, Gong J, Seminara D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D, Cotterchio M, Campbell PT, Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan AT, Peters U, Chang-Claude J. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk . Br J Cancer. 2016 Jan 19;114(2):221-9. doi: 10.1038/bjc.2015.443